Publicaciones en las que colabora con HERMINIA GONZALEZ NAVARRO (22)

2024

  1. Asociación de la placa de ateroma carotídea con los niveles plasmáticos de IL-18 y con polimorfismos en el gen del receptor de la IL-18 en la población mediterránea

    Clínica e investigación en arteriosclerosis, Vol. 36, Núm. 4, pp. 210-217

  2. Light deficiency in Apoe−/−mice increases atheroma plaque size and vulnerability by modulating local immunity

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 4

  3. Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice

    Journal of Nutritional Biochemistry, Vol. 134

2023

  1. Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor

    Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 1, pp. 1-11

2022

  1. Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists

    Nutrients, Vol. 14, Núm. 18

  2. Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor

    Clinica e Investigacion en Arteriosclerosis

2021

  1. Dissecting abdominal aortic aneurysm is aggravated by genetic inactivation of light (Tnfsf14)

    Biomedicines, Vol. 9, Núm. 11

  2. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects

    International Journal of Clinical Practice, Vol. 75, Núm. 4

  3. Therapies for the treatment of cardiovascular disease associated with type 2 diabetes and dyslipidemia

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-27

2020

  1. Dapagliflozin does not modulate atherosclerosis in mice with insulin resistance

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-18

  2. Impact of cholesterol metabolism in immune cell function and atherosclerosis

    Nutrients, Vol. 12, Núm. 7, pp. 1-19

  3. Srebf2 locus overexpression reduces body weight, total cholesterol and glucose levels in mice fed with two different diets

    Nutrients, Vol. 12, Núm. 10, pp. 1-15

2019

  1. Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 767-773

  2. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  3. Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: Changes in cytokine/chemokine profile, increased platelet and leukocyte activation

    Journal of Clinical Medicine, Vol. 8, Núm. 1

  4. Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes

    Journal of Translational Medicine, Vol. 17, Núm. 1

2017

  1. The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype

    Diabetologia, Vol. 60, Núm. 9, pp. 1801-1812

2016

  1. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/lymphotoxin β-receptor pathway

    Thrombosis and Haemostasis, Vol. 116, Núm. 2, pp. 379-393

  2. Increased thioredoxin levels are related to insulin resistance in familial combined hyperlipidaemia

    European Journal of Clinical Investigation, Vol. 46, Núm. 7, pp. 636-642

  3. Unsaturated oral fat load test improves glycemia, insulinemia and oxidative stress status in nondiabetic subjects with abdominal obesity

    PLoS ONE, Vol. 11, Núm. 8